Down-Regulation of Colonic ACE2 Expression in Patients With Inflammatory Bowel Disease Responding to Anti-TNF Therapy: Implications for COVID-19

by Xiao-Zhi Li, Yun Qiu, Louisa Jeffery, Louisa Jeffery, Fen Liu, Rui Feng, Jin-Shen He, Jin-Yu Tan, Zi-Yin Ye, Si-Nan Lin, Subrata Ghosh, Subrata Ghosh, Marietta Iacucci, Marietta Iacucci, Min-Hu Chen, Ren Mao
Published 2021-01-01

Genetic variation at the CD28 locus and its impact on expansion of pro-inflammatory CD28 negative T cells in healthy individuals

by Evaggelia Liaskou, Louisa Jeffery, Dimitrios Chanouzas, Blagoje Soskic, Michael F. Seldin, Lorraine Harper, David Sansom, Gideon M. Hirschfield
Published 2017-08-01

Immune checkpoint inhibitor-associated gastrointestinal and hepatic adverse events and their management

by Uday N. Shivaji, Louisa Jeffery, Xianyong Gui, Samuel C. L. Smith, Omer F. Ahmad, Ayesha Akbar, Subrata Ghosh, Marietta Iacucci
Published 2019-11-01